Growth of Infants Fed Hydrolysate Formulas

Abbott

Status: Completed

Conditions: Growth and Tolerance

Treatments: Other: Powder Infant Formula; Other: RTF Infant Formula

Study type: Interventional

Funder types: Industry

Identifiers

NCT02006992

AJ57

Details and patient eligibility

About

Effects on weight and weight gain will be monitored in healthy term infants fed assigned infant formulas.

Enrollment: 195 patients

Sex: All

Ages: Under 9 days old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Infants in good health.
• Singleton, term birth with a gestational age of 37 to 42 weeks.
• Birth weight of 2500 g (5 lb 8 oz) or greater.
• Between 0 and 9 days of age at enrollment.
• Not receiving vitamin or mineral supplements.

Exclusion criteria

• Maternal, fetal or perinatal medical history with potential for adverse effects on growth or development.

Trial design

195 participants in 2 patient groups

RTF Infant Formula 1

Active Comparator group

Description:

a ready to feed (RTF) extensively hydrolyzed infant formula fed ad lib.

Treatment:

Other: RTF Infant Formula

Powder Infant Formula 2

Experimental group

Description:

a powdered extensively hydrolyzed infant formula fed ad lib.

Treatment:

Other: Powder Infant Formula